These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1322348)

  • 1. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.
    Yoshioka K; Kakumu S; Wakita T; Ishikawa T; Itoh Y; Takayanagi M; Higashi Y; Shibata M; Morishima T
    Hepatology; 1992 Aug; 16(2):293-9. PubMed ID: 1322348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver.
    Hosoda K; Omata M; Yokosuka O; Kato N; Ohto M
    Hepatology; 1992 May; 15(5):777-81. PubMed ID: 1314769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.
    Qu D; Li JS; Vitvitski L; Mechai S; Berby F; Tong SP; Bailly F; Wang QS; Martin JL; Trépo C
    J Hepatol; 1994 Jul; 21(1):70-5. PubMed ID: 7963424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.
    Tsubota A; Chayama K; Ikeda K; Yasuji A; Koida I; Saitoh S; Hashimoto M; Iwasaki S; Kobayashi M; Hiromitsu K
    Hepatology; 1994 May; 19(5):1088-94. PubMed ID: 8175130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis C virus RNA by nested polymerase chain reaction in sera of patients with chronic non-A, non-B hepatitis treated with interferon.
    Kobayashi Y; Watanabe S; Konishi M; Yokoi M; Ikoma J; Kakehashi R; Kojima Y; Suzuki S
    J Hepatol; 1992 Sep; 16(1-2):138-44. PubMed ID: 1336504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.
    Squadrito G; Leone F; Sartori M; Nalpas B; Berthelot P; Raimondo G; Pol S; Bréchot C
    Gastroenterology; 1997 Aug; 113(2):567-72. PubMed ID: 9247477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.
    Castillo I; Bartolomé J; Navas S; Gonzalez S; Herrero M; Carreño V
    Hepatology; 1994 Jun; 19(6):1342-6. PubMed ID: 8188165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
    Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
    Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy.
    Hino K; Okuda M; Konishi T; Ishiko H; Okita K
    Dig Dis Sci; 1995 Jan; 40(1):14-20. PubMed ID: 7821101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene.
    Enomoto N; Sato C; Kurosaki M; Marumo F
    J Hepatol; 1994 Feb; 20(2):252-61. PubMed ID: 8006407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction.
    Inchauspe G; Abe K; Zebedee S; Nasoff M; Prince AM
    Hepatology; 1991 Oct; 14(4 Pt 1):595-600. PubMed ID: 1655606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis.
    Takada N; Takase S; Takada A
    Gastroenterol Jpn; 1993 Apr; 28(2):268-75. PubMed ID: 8387438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.
    Giannini C; Thiers V; Nousbaum JB; Stuyver L; Maertens G; Bréchot C
    J Hepatol; 1995 Sep; 23(3):246-53. PubMed ID: 8550987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
    Shindo M; Arai K; Okuno T
    J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.